Significantly lower APN levels have been shown in women with breast cancer compared to healthy controls, especially during the postmenopausal period, suggesting that APN might influence proliferation of breast cancer cells in a low estrogen environment [70,74,75,76]. This evidence concerns the gene ANPEP and breast cancer.